Individuals with FA-DLBCL are typically males (~70% of cases) aged 25–96 years (~75% of cases are >50 years old). They present with abnormalities<unk>  with a long-standing (1–20 years): a) cardiac myxoma (i.e. a myxoid tumor of primitive connective tissue in the heart's atrium); b) subdural hematoma (i.e. a collection of blood between the inner layer of the dura mater and the arachnoid mater of the meninges surrounding the brain; c) testicular hyrocoele (i.e. fluid accumulation within the potential space between the two layers of the cavum vaginale, of a testicle); d) pseudocyst (i.e. a cyst that lacks epithelial or endothelial cells) or cyst of the kidneys, spleen, ovary, adrenal gland, retroperitoneal space, or other tissue; and e) intravascular thrombi; f) implants of a foreign body such as an artificial heart valve, joint replacement, or metal stent (i.e. a tube placed within a blood vessel to keep it open). Most cases have involved atrial myxomas (~31%), pseudocysts (~28%), prosthetic devices (23%), and chronic hematoma (18%). Symptoms of the disease are attributable to the pre-existing condition, not the FA-DLBCL that has developed in the immune-sequestered site.
Fibrin-associated diffuse large B-cell lymphoma
Nodal marginal zone B cell lymphoma
Marginal zone B-cell lymphoma
Pediatric-type follicular lymphoma
Diffuse large B-cell lymphoma
Splenic marginal zone lymphoma
Chronic multifocal Langerhans cell histiocytosis
Epstein–Barr virus positive diffuse large B-cell lymphoma, not otherwise specified